Description
SWOT ANALYSIS OF SHIRE
Shire
Parent Company
Shire
Category
Pharmaceuticals
Sector
Healthcare
Tagline/ Slogan
To be as brave as people we help; Better lives for patients
It is one of the world’s leading specialty healthcare solutions company USP offering solutions to people suffering from life altering conditions
STP
Human genetic therapies, gastrointestinal diseases, attention deficit Segment hyperactivity disorders
Target Group
Specialty healthcare professionals
Shire is company which aims to enable people with life altering Positioning situations to lead better lives
SWOT Analysis
1. They have over 5000 well trained employees in 29 countries 2. They operate in niche segments such as ADHD where there is less competition 3. Strong product pipeline with many drugs at maturity stage Strength 4. Their VYVANCE is blockbuster drug in ADHD all over the world
1. Limited presence in emerging markets Weakness 2. Majority of their revenue comes only from America & Europe region
1. Increasing number of chronic diseases 2. Increasing awareness about disorders such as ADHD Opportunity 3. Better detection techniques for ADHD
1. Economic trouble in euro zone which is major revenue source for company 2. Increasing competitions from companies such as Eli lilly, Novartis Threats 3. FDA guideline for drug development are increasingly becoming more
stringent
Competition
1. Eli Lilly 2. Otsula holdings 3. Johnson & Johnson Competitors 4. Novartis AG
doc_763451521.docx
SWOT ANALYSIS OF SHIRE
Shire
Parent Company
Shire
Category
Pharmaceuticals
Sector
Healthcare
Tagline/ Slogan
To be as brave as people we help; Better lives for patients
It is one of the world’s leading specialty healthcare solutions company USP offering solutions to people suffering from life altering conditions
STP
Human genetic therapies, gastrointestinal diseases, attention deficit Segment hyperactivity disorders
Target Group
Specialty healthcare professionals
Shire is company which aims to enable people with life altering Positioning situations to lead better lives
SWOT Analysis
1. They have over 5000 well trained employees in 29 countries 2. They operate in niche segments such as ADHD where there is less competition 3. Strong product pipeline with many drugs at maturity stage Strength 4. Their VYVANCE is blockbuster drug in ADHD all over the world
1. Limited presence in emerging markets Weakness 2. Majority of their revenue comes only from America & Europe region
1. Increasing number of chronic diseases 2. Increasing awareness about disorders such as ADHD Opportunity 3. Better detection techniques for ADHD
1. Economic trouble in euro zone which is major revenue source for company 2. Increasing competitions from companies such as Eli lilly, Novartis Threats 3. FDA guideline for drug development are increasingly becoming more
stringent
Competition
1. Eli Lilly 2. Otsula holdings 3. Johnson & Johnson Competitors 4. Novartis AG
doc_763451521.docx